Trial Profile
Phase IV, Randomized, Open-Label Trial Comparing Long-Term Subcutaneous Low-Molecular Weight Heparin [tinzaparin sodium] With Oral Anticoagulant Therapy [acenocoumarol] in the Treatment of Deep Venous Thrombosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jun 2009
Price :
$35
*
At a glance
- Drugs Tinzaparin sodium (Primary) ; Acenocoumarol
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- 28 Jun 2008 New trial record.